Revisiones_bibliográficas TyO

Google+

lunes, 27 de marzo de 2017

Curso de Rehabilitación Geriátrica y de Piso Pélvico

http://www.medicina-rehabilitacion.com/medicina-fisica/curso-de-rehabilitacion-geriatrica-y-de-piso-pelvico/

Curso de Rehabilitación Geriátrica y de Piso Pélvico » Especialista en Medicina Física y Rehabilitación

www.comefyr.org.mx/cursogeriatria.html

COMEFYR

20 de marzo a las 15:41

Compartimos el temario y ponentes del Curso de Rehabilitación Geriátrica y de Piso Pélvico.

Aval: UNAM Posgrado
12-14 Mayo 2017
Límite de inscripción 26 Abril.

Viernes 12: 15:00 a 20:00h
Sábado: 09:00-18:00
Domingo: 09:00-17:30

Sede: Auditorio de la Asociación Mexicana de Contadores Públicos.
Calle Esperanza 765. Col. Narvarte.

Dirigido a: Médicos residentes y especialistas en medicina de rehabilitación y especialidades afines (geriatría, medicina interna, medicina familiar, etc)

Costo:
$2,600 médicos especialistas
$1,800 médico residentes

____________________________________
Proceso de inscripción:
____________________________________
1. Enviar correo electrónico indicando su nombre completo y anexando escaneado:
A. título y cédula de medicina general B. Título y cédula profesional de especialidad en el caso de egresados o bien carta de asignación de médicos residentes.
Al correo: presidente@comefyr.org.mx

2. Al enviar este mail recibirá una clave de registro así como el formato de registro a la UNAM, pudiendo realizar su pago en la modalidad que le resulte más conveniente.

3. Deberá llenar el formado de registro a la UNAM (completo y firmado) y enviar al mismo correo junto con su ficha de pago para concluir con su proceso de inscripción.

4. El trámite de inscripción enviando TODOS los documentos y ficha de pago deberán ser enviados antes del 26 de Abril. Este es un requisito indispensable para quedar inscrito en el curso ante la UNAM y poder obtener la constancia al finalizar el curso.

Anexo! ::::: >El pago podrá realizarlo en la cuenta bancaria o si desea pago con tarjeta de crédito puede realizarlo en Insurgentes sur 591 piso 4. Col. Nápoles. Frente a estación La Piedad del Metrobús (10:00 a 14:00 y de 16:30 a 19:00)

www.comefyr.org.mx/cursogeriatria.html

#medicina de rehabilitación #geriatria #piso pelvico

Artrogriposis: manifestaciones clínicas y tratamiento

http://www.ortopediapediatricaisunza.com.mx/academia/artrogriposis-manifestaciones-clinicas-y-tratamiento/

Arthrogryposis: clinical manifestations and management

Fuente
Este artículo es originalmente publicado en:

https://www.ncbi.nlm.nih.gov/pubmed/26141802

http://www.sciencedirect.com/science/article/pii/S0929693X15002079

De:

Ayadi K1,Trigui M2,Abid A1,Cheniour A1,Zribi M1,Keskes H1

Arch Pediatr.

2015 Aug;22(8):830-9. doi: 10.1016/j.arcped.2015.05.014. Epub 2015 Jul 2.

Abstract

INTRODUCTION:

Arthrogryposis is a condition existing at birth, seen in different diseases that have in common the existence of multiple joint stiffness. The clinical presentation is diversified and the functional prognosis depends on the etiology, which makes therapeutic options different from one case to another. The objective of this study was to describe clinical manifestations observed in arthrogrypotic patients and show the different therapeutic methods and functional results.

CONCLUSION:

Arthrogryposis has different clinical presentations. Successful treatment is not constant. Multidisciplinary care is necessary and should be early and continued in order to gain the maximum autonomy and facilitate patients’ social integration.

Resumen
INTRODUCCIÓN:
La artrogriposis es una condición existente en el nacimiento, visto en diferentes enfermedades que tienen en común la existencia de rigidez articular múltiple. La presentación clínica se diversifica y el pronóstico funcional depende de la etiología, lo que hace que las opciones terapéuticas sean diferentes de un caso a otro. El objetivo de este estudio fue describir las manifestaciones clínicas observadas en pacientes con artrogriposis y mostrar los diferentes métodos terapéuticos y resultados funcionales.

CONCLUSIÓN:
La artrogriposis tiene diferentes presentaciones clínicas. El tratamiento exitoso no es constante. El cuidado multidisciplinario es necesario y debe ser temprano y continuado con el fin de obtener la máxima autonomía y facilitar la integración social de los pacientes.

PMID: 26141802 DOI:

10.1016/j.arcped.2015.05.014

[Indexed for MEDLINE]

#artrogriposis

Bloqueo neuromuscular en ancianos / Neuromuscular blockade in geriatris

Marzo 27, 2017. No. 2641

Bloqueo neuromuscular en el paciente anciano

Neuromuscular blockade in the elderly patient.

Lee LA1, Athanassoglou V1, Pandit JJ1.

J Pain Res. 2016 Jun 17;9:437-44. doi: 10.2147/JPR.S85183. eCollection 2016.Abstract

Neuromuscular blockade is a desirable or even essential component of general anesthesia for major surgical operations. As the population continues to age, and more operations are conducted in the elderly, due consideration must be given to neuromuscular blockade in these patients to avoid possible complications. This review considers the pharmacokinetics and pharmacodynamics of neuromuscular blockade that may be altered in the elderly. Compartment distribution, metabolism, and excretion of drugs may vary due to age-related changes in physiology, altering the duration of action with a need for reduced dosage (eg, aminosteroids). Other drugs (atracurium, cisatracurium) have more reliable duration of action and should perhaps be considered for use in the elderly. The range of interpatient variability that neuromuscular blocking drugs may exhibit is then considered and drugs with a narrower range, such as cisatracurium, may produce more predictable, and inherently safer, outcomes. Ultimately, appropriate neuromuscular monitoring should be used to guide the administration of muscle relaxants so that the risk of residual neuromuscular blockade postoperatively can be minimized. The reliability of various monitoring is considered. This paper concludes with a review of the various reversal agents, namely, anticholinesterase drugs and sugammadex, and the alterations in dosing of these that should be considered for the elderly patient.

KEYWORDS: anesthesia; drugs; elderly; pharmacodynamics; pharmacokinetics

PDF

Relajantes neuromusculares en el anciano

Neuromuscular blockade in the elderly.

Stankiewicz-Rudnicki M1.

Anaesthesiol Intensive Ther. 2016;48(4):257-260. doi: 10.5603/AIT.2016.0045.

Abstract

The aim of the presented review is to highlight the clinical problem of postoperative residual curarization (PORC) following general anaesthesia in the elderly. Possible complications of PORC are described along with age-induced changes in pharmacokinetics of long and intermediate-acting neuromuscular blocking agents. This is intended to facilitate the selection and to promote appropriate intraoperative use of muscle relaxants in patients over the age of 65 years.

KEYWORDS: elderly patients; muscle relaxants; neuromuscular block; postoperative residual curarization; reversal

PDF

Relación entre la concentración efectiva el sitio diana de rocuronio y el grado de recuperación del bloqueo neuromuscular en pacientes de edad avanzada.

The relationship between the target effective site concentration of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients.

Fan X1, Ma M1, Li Z1, Gong S1, Zhang W1, Wen Y1.

Int J Clin Exp Med. 2015 Sep 15;8(9):16369-73. eCollection 2015.

Abstract

OBJECTIVE: To study the relationship between the target effective site concentration (Ce) of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients. METHODS: 50 elderly patients (ASA grade II) scheduled for selective surgical procedure under general anaesthesia were randomly divided into two groups, A and B, with 25 cases in each group. The Ce of rocuronium for intubation was 3 μg·ml(-1) in both groups, and the Ce during operation were 0.8 and 1.0 μg·ml(-1) in group A and B, respectively. When target controlled infusion of rocuronium was stopped, without the administration of reversal agents for neuromuscular blockade, the relationship between Ce and the first twitch height (T1) was studied by regression analysis. RESULTS: There was a significant linear relationship between Ce and T1, and there was no statistical difference in regression coefficient and interception between group A and B (P>0.05). CONCLUSION: The degree of recovery from neuromuscular blockade could be judged by the target effective site concentration of rocuronium at the time of reversal from neuromuscular blockade in the elderly patients.

KEYWORDS: Rocuronium; geriatrics; neuromuscular blockade; pharmacodynamics

PDF